Compare FTRE & ASST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTRE | ASST |
|---|---|---|
| Founded | 1996 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.0B |
| IPO Year | 2023 | 2022 |
| Metric | FTRE | ASST |
|---|---|---|
| Price | $18.04 | $12.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $14.06 | ★ $23.50 |
| AVG Volume (30 Days) | 1.4M | ★ 4.4M |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 82.56 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,723,400,000.00 | $633,489.00 |
| Revenue This Year | N/A | $294.91 |
| Revenue Next Year | $3.09 | $12.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 1.00 | ★ 128.67 |
| 52 Week Low | $4.46 | $0.49 |
| 52 Week High | $18.67 | $19.75 |
| Indicator | FTRE | ASST |
|---|---|---|
| Relative Strength Index (RSI) | 62.82 | 43.03 |
| Support Level | $15.40 | $10.53 |
| Resistance Level | $18.13 | $13.80 |
| Average True Range (ATR) | 0.90 | 0.95 |
| MACD | -0.05 | 0.05 |
| Stochastic Oscillator | 80.00 | 54.68 |
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
Strive Inc is a structured finance company and institutional asset manager focused on disciplined capital allocation and long term value creation. The company has adopted bitcoin as its hurdle rate for capital deployment because of its fiduciary duty to maximize long-term value for stockholders, and compounding purchasing power over time. It operates in two reportable operating segments: the Asset Management segment, which provides investment advisory services and the Corporate & Other segment, which includes the company's bitcoin treasury operations. The majority of the revenue is derived from the Asset Management segment.